Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Esophagus”

486 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 486 results

Testing effectiveness (Phase 2)WithdrawnNCT03592407
What this trial is testing

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center
Not applicableStudy completedNCT01032044
What this trial is testing

CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia

Who this might be right for
Barrett SyndromeBarrett's SyndromeBarrett's Esophagus+2 more
Mauna Kea Technologies 164
Not applicableStudy completedNCT01882478
What this trial is testing

Cryotherapy -BEATS-RF Ablation Trial

Who this might be right for
Barrett's Esophagus With Persistent Dysplasia orEarly Esophageal Adenocarcinoma Post Radio Frequency Ablation
Mayo Clinic 15
Not applicableStudy completedNCT03429816
What this trial is testing

OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

Who this might be right for
Gastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma+2 more
University Hospital Heidelberg 120
Testing effectiveness (Phase 2)Ended earlyNCT01182610
What this trial is testing

Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal AdenocarcinomaAdenocarcinoma of the Distal EsophagusAdenocarcinomas of the Gastroesophageal Junction+1 more
Accelerated Community Oncology Research Network 1
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Testing effectiveness (Phase 2)Study completedNCT01217060
What this trial is testing

Trimodality Management of T1b Esophageal Cancers

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT03288350
What this trial is testing

MDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 55
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Not applicableStudy completedNCT07309991
What this trial is testing

Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy

Who this might be right for
Esophageal CarcinomaEsophageal AdenocarcinomaEsophagectomy+2 more
Sun Yat-sen University 2,083
Not applicableUnknownNCT03427346
What this trial is testing

Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection

Who this might be right for
Barrett EsophagusBarrett AdenocarcinomaEsophagus Neoplasm
Universitätsklinikum Hamburg-Eppendorf 407
Not applicableStudy completedNCT03060642
What this trial is testing

The Microenvironment in Barrett's Esophagus

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Columbia University 155
Not applicableEnrolling By InvitationNCT07212491
What this trial is testing

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Mayo Clinic 300
Not applicableStudy completedNCT05628441
What this trial is testing

Real-time Computer Aided Detection of Barrett's Neoplasia

Who this might be right for
Barrett EsophagusBarrett Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Large-scale testing (Phase 3)Study completedNCT00003118
What this trial is testing

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)UnknownNCT00005607
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
Robert H. Lurie Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)Ended earlyNCT00216008
What this trial is testing

Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.

Who this might be right for
Esophageal AdenocarcinomasAdenocarcinomas of the Gastroesophageal Junction
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)Study completedNCT00086996
What this trial is testing

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 98
Load More Results